Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001852075-26-000002

Director acquired 3,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dar Zavain Director 2026-01-02 Grant or award +3,571 142,329 D: show line 1 in the form
Loading xslF345X05/wk-form4_1767739668.xml…